4
Changes in Ownership
Protagenic Therapeutics, Inc.new Filed Acc 0001144204-08-033296
10% owner bought 70,000 shares at an average $4.28 ($299,751)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Trinad Capital Master Fund Ltd. 10% owner | 2008-05-30 | Purchase | +35,000 | $4.56 | $159,751 | 2,213,170 | D |
| Trinad Capital Master Fund Ltd. 10% owner | 2008-06-02 | Purchase | +35,000 | $4.00 | $140,000 | 2,248,170 | D |
| Open-market purchases · 70,000 sh · avg $4.28 · $299,751 | |||||||
Loading xslF345X02/v116422_ex.xml…